174900 — AbClon Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual income statement for AbClon, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS/A	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,018	3,404	2,877	2,340	4,714
Cost of Revenue
Gross Profit	1,618	2,389	2,070	1,077	1,140
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	13,247	12,144	14,686	17,929	22,350
Operating Profit	-10,229	-8,740	-11,809	-15,589	-17,636
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-10,238	-10,339	-12,893	-16,302	-17,909
Provision for Income Taxes
Net Income After Taxes	-10,238	-9,244	-12,904	-16,302	-17,907
Net Income Before Extraordinary Items
Net Income	-10,238	-9,244	-12,904	-16,302	-17,907
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-10,238	-9,364	-13,054	-16,421	-18,104
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-670	-612	-843	-975	-976
Dividends per Share